 | Up a level |
Journal Article
Gorska, A., Gruchala-Niedoszytko, M., Niedoszytko, M., Rabenhorst, A., Sperr, W., Elberink, Oude J., Lange, M., Gleixner, K., Brazzelli, V, Fontana, E., Vos, B., Reiter, A., Schwaab, J., Zanotti, R., Bonadonna, P., Triggiani, M., Gotlib, J., Doubek, M., Jakob, T., Fuchs, D., Sabato, V, Zink, A., Bretterklieber, A., Jaekel, N., Sotlar, K., Horny, H., Fortina, Belloni A., Merante, S., Kluin-Nelemans, H., Valent, P. and Hartmann, K. (2017). The body mass index is an indicator of advanced systemic mastocytosis: preliminary results from a registry project of the European Competence Network on Mastocytosis (ECNM) registry. Allergy, 72. S. 126 - 128. HOBOKEN: WILEY. ISSN 1398-9995
Jawhar, M., Naumann, N., Knut, M., Score, J., Ghazzawi, M., Schneider, B., Kreuzer, K. -A., Hallek, M., Chacko, J., Wallis, L., Schwaab, J., Metzgeroth, G., Hofmann, W. -K., Fabarius, A., Chase, A., Tapper, W., Cross, N. C. P. and Reiter, A. (2017). Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasm with eosinophilia. Oncol. Res. Treat., 40. S. 150 - 151. BASEL: KARGER. ISSN 2296-5262
Jawharl, M., Naumann, N., Schwaab, J., Dietz, C., Casper, J., Dang, T. A., Dietze, L., Doehner, K., Haenel, A., Lathan, B., Link, H., Lotfti, S., Mielkel, S., Luber, V., Maywald, O., Mueller, L., Platzbecker, U., Pruemmer, O., Thomssen, H., Toepelt, K., Schmitt, K., Baurmann, H., Vielert, T., Hofmann, W. K., Haferlach, C., Cross, N. C., Fabarius, A., Reiter, A. and Metzgeroth, G. (2016). CLINICAL CHARACTERISTICS AND LONG-TERM OUTCOME ON IMATINIB IN PATIENTS WITH MYELOID/LYMPHOID NEOPLASMS AND ASSOCIATED PDGFRB FUSION GENES IN CHRONIC OR BLAST PHASE. Haematologica, 101. S. 264 - 266. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
Niedoszytko, M., Gorska, A., Nedoszytko, B., Rabenhorst, A., Sperr, W., Elberink, Oude J., Lange, M., Gleixner, K., Brazzelli, V, Fontana, E., Vos, B., Reiter, A., Schwaab, J., Zanotti, R., Bonadonna, P., Triggiani, M., Gotlib, J., Doubek, M., Jakob, T., Fuchs, D., Sabato, V, Zink, A., Bretterklieber, A., Jaekel, N., Sotlar, K., Horny, H., Fortina, Belloni A., Merante, S., Kluin-Nelemans, H., Valent, P. and Hartmann, K. (2017). Impact of allergic disorders and anaphylaxis in mastocytosis: Preliminary data from a study of the European Competence Network on Mastocytosis (ECNM) registry. Allergy, 72. S. 212 - 214. HOBOKEN: WILEY. ISSN 1398-9995
Rabenhorst, A., Annecke, T., Drinhaus, H., Schroeder, D., Gehring, M., Leja, S., Schwaab, J., Reiter, A., Raap, U. and Hartmann, K. (2017). Glycocalyx shedding in mastocytosis correlates with disease severity. Exp. Dermatol., 26 (3). S. E8 - 1. HOBOKEN: WILEY. ISSN 1600-0625
Rabenhorst, A., Leja, S., Schwaab, J., Gehring, M., Foerster, A., Reiter, A., Raap, U. and Hartmann, K. (2016). Serum levels of programmed cell death ligand-1 are increased in mastocytosis and correlate with disease severity. Exp. Dermatol., 25 (3). S. E1 - 1. HOBOKEN: WILEY. ISSN 1600-0625
Rabenhorst, A., Sperr, W., Elberink, J. Oude, Lange, M., Gleixner, K., Brazzelli, V., Fontana, E., Vos, B., Gorska, A., Reiter, A., Schwaab, J., Zanotti, R., Bonadonna, P., Triggiani, M., Gotlib, J., Doubek, M., Jakob, T., Kilbertus, A., Sabato, V., Zink, A., Bretterklieber, A., Jaekel, N., Sotlar, K., Horny, H., Fortina, A. Belloni, Merante, S., Niedoszytko, M., Kluin-Nelemans, H., Valent, P. and Hartmann, K. (2017). Age at disease onset has a major impact on clinical characteristics and course of mastocytosis. Exp. Dermatol., 26 (3). S. E6 - 1. HOBOKEN: WILEY. ISSN 1600-0625
Reiter, A., Kluin-Nelemans, H. C., George, T., Akin, C., DeAngelo, D. J., Hermine, O., Awan, F., Hexner, E., Mauro, M., Schwaab, J., Jawhar, M., Sternberg, D., Berkowitz, N., Niolat, J., Labed, A. Huntsman, Hartmann, K., Horny, H-P., Valent, P. and Gotlib, J. (2017). POOLED SURVIVAL ANALYSIS OF MIDOSTAURIN CLINICAL STUDY DATA (D2201+A2213) IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS COMPARED WITH HISTORICAL CONTROLS. Haematologica, 102. S. 321 - 323. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078